111 related articles for article (PubMed ID: 31907615)
61. The prevalence of human papillomavirus among women in northern Guangdong Province of China.
Huang W; Xu H; Hu H; Zhang D; Liu Y; Guo Y; Xiao F; Chen W; Ma Z
Sci Rep; 2022 Aug; 12(1):13353. PubMed ID: 35922661
[TBL] [Abstract][Full Text] [Related]
62. Cervical HPV infection in Yueyang, China: a cross-sectional study of 125,604 women from 2019 to 2022.
Hou J; Zeng M; Liu C; Xie B; Li Y; Wu L; Zhu L; Li M; Zhang Z; Zhang X; Ge Y
Front Public Health; 2023; 11():1210253. PubMed ID: 37601194
[TBL] [Abstract][Full Text] [Related]
63. HPV prevalence and distribution characteristics in postmenopausal women from Nanjing, China.
Yin X; Zhang C; Wu X; Feng J; Xie J; Li Y
BMC Womens Health; 2024 Jan; 24(1):68. PubMed ID: 38267981
[TBL] [Abstract][Full Text] [Related]
64. Prevalence and genotype distribution of human papillomavirus among 29 263 women from the Longgang community of Shenzhen.
Chen T; Cai S; Lin J; Yang X; He X; Tu C; Yang C
Trans R Soc Trop Med Hyg; 2022 Feb; 116(2):173-178. PubMed ID: 34263317
[TBL] [Abstract][Full Text] [Related]
65. Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.
Lee SH; Vigliotti VS; Pappu S
J Clin Pathol; 2010 Mar; 63(3):235-9. PubMed ID: 19858529
[TBL] [Abstract][Full Text] [Related]
66. Human papillomavirus infection rates before and after the introduction of prophylactic vaccines in Kunming, Yunnan, China.
Z G; D Z; X Y; W Q; F X; B L; Z H; S Y
Indian J Med Microbiol; 2020; 38(1):66-71. PubMed ID: 32719211
[TBL] [Abstract][Full Text] [Related]
67. Trends in cocirculation of oncogenic HPV genotypes in single and multiple infections among the unvaccinated community.
Vazifehdoost M; Eskandari F; Sohrabi A
J Med Virol; 2022 Jul; 94(7):3376-3385. PubMed ID: 35261047
[TBL] [Abstract][Full Text] [Related]
68. Prevailing of HPV-16 and 52 genotype in 2022-2023 in Sanandaj, Iran.
Haddadi M; Atefmehr L; Motlaghzadeh S; Hejami F; Elyasi FS; Zafarian N; Taghiabadi Z; Aboofazeli A; Yarahmady H; Modaresi P; Dadgar A; Arbabinia M; Naderisemiromi M; Najafpour S; Sharifi A; Gholami A; Mamandi A; Letafati A
Virol J; 2024 May; 21(1):106. PubMed ID: 38715018
[TBL] [Abstract][Full Text] [Related]
69. HPV Prevalence and Genotype Distribution Among Women From Hengyang District of Hunan Province, China.
Tang SY; Liao YQ; Hu Y; Shen HY; Wan YP; Wu YM
Front Public Health; 2021; 9():710209. PubMed ID: 34805062
[TBL] [Abstract][Full Text] [Related]
70. Prevalence of human papillomavirus in Wenzhou, China: a cross-sectional study of 127 938 outpatient women.
Zhang M; Chen G; Dai X; Wu Z; Huang H; Zheng Y
BMJ Open; 2022 Dec; 12(12):e066698. PubMed ID: 36581425
[TBL] [Abstract][Full Text] [Related]
71. Four-year analysis of high-risk human papillomavirus infection among women in rural areas of Nyingchi City, Tibet.
Li J; Li X; Sheng X
Front Public Health; 2023; 11():1251440. PubMed ID: 37799153
[TBL] [Abstract][Full Text] [Related]
72. Prevalence and distribution of human papillomavirus infection in Korean women as determined by restriction fragment mass polymorphism assay.
Lee EH; Um TH; Chi HS; Hong YJ; Cha YJ
J Korean Med Sci; 2012 Sep; 27(9):1091-7. PubMed ID: 22969258
[TBL] [Abstract][Full Text] [Related]
73. Development of a sensitive droplet digital PCR according to the HPV infection specificity in Chinese population.
Lv N; Zhao Y; Song Y; Ji M; Zhou Y
BMC Cancer; 2023 Oct; 23(1):1022. PubMed ID: 37872500
[TBL] [Abstract][Full Text] [Related]
74. Human papillomavirus prevalence and genotype distribution landscapes in Shannan City, Tibet Tibetan Autonomous Region, China.
Feng D; Wei S; Chen J; Yu Z; Lhamo Y; Wang H; Zhu X
Virol J; 2022 Mar; 19(1):46. PubMed ID: 35303926
[TBL] [Abstract][Full Text] [Related]
75. Analysis of age-specified and genotype distribution of HPV multiple infections in the Chinese population.
Zhou YX; Ma XH; Wang TT; Qu XL; Zhang XQ
Sci Rep; 2024 Feb; 14(1):2678. PubMed ID: 38302588
[TBL] [Abstract][Full Text] [Related]
76. Genetic characteristics of human papillomavirus type 16, 18, 52 and 58 in southern China.
Zu Y; Ou Z; Wu D; Liu W; Liu L; Wu D; Zhao Y; Ren P; Zhang Y; Li W; Fu S; Wen Y; Cai X; Liao W; Geng C; Zhou H; Wang X; Lu H; Peng H; Liu N; Zhu S; Liu J; Wang D; Li J
Genomics; 2021 Nov; 113(6):3895-3906. PubMed ID: 34555497
[TBL] [Abstract][Full Text] [Related]
77. Prevalence and Genotype Distribution of Human Papillomavirus Among Healthy Females in Beijing, China, 2016-2019.
Yu H; Yi J; Dou YL; Chen Y; Kong LJ; Wu J
Infect Drug Resist; 2021; 14():4173-4182. PubMed ID: 34675562
[TBL] [Abstract][Full Text] [Related]
78. Prevalence of mucosal and cutaneous human papillomavirus in Moroccan breast cancer.
ElAmrani A; Gheit T; Benhessou M; McKay-Chopin S; Attaleb M; Sahraoui S; El Mzibri M; Corbex M; Tommasino M; Khyatti M
Papillomavirus Res; 2018 Jun; 5():150-155. PubMed ID: 29660489
[TBL] [Abstract][Full Text] [Related]
79. Prevalence and genotype distribution of human papillomavirus among Hakka women in China.
Zeng XX; Yan LX; Huang XX; He CH; Liu WG; Yuan WQ; Qiu YP; Liu ZX
Ann Transl Med; 2016 Aug; 4(15):276. PubMed ID: 27570770
[TBL] [Abstract][Full Text] [Related]
80. Epidemiological characteristics and transmissibility of HPV infection: A long-term retrospective study in Hokkien Golden Triangle, China, 2013-2021.
Xu J; Abudurusuli G; Rui J; Li Z; Zhao Z; Xia Y; Guo X; Abudunaibi B; Zhao B; Guo Q; Cui JA; Zhou Y; Chen T
Epidemics; 2023 Sep; 44():100707. PubMed ID: 37480747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
